Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
Convalescent plasma Emergency use authorization Experimental Antiviral Mar/30/2021 34 6
Omega-3 polyunsaturated fatty acids Potential treatment - clinical evidence Natural product Unknown Mar/29/2021 1 0
3,3'-(Biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonic acid) Potential treatment - theoretical effect Experimental Antiviral Mar/26/2021 1 0
Velpatasvir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/26/2021 1 0
Torin 2 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 3 0
Vistusertib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 2 0
Phycoerythrobilin Potential treatment - theoretical effect Natural product Antiviral Mar/20/2021 1 0
Phycourobilin Potential treatment - theoretical effect Natural product Antiviral Mar/20/2021 1 0
Phycocyanobilin Potential treatment - theoretical effect Natural product Antiviral Mar/20/2021 1 0